🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Philip Morris exec sells $1.04m in stock

Published 08/13/2024, 04:42 AM
© Reuters
PM
-

Philip Morris International Inc. (NYSE:PM) President for the Europe Region, Massimo Andolina, has recently sold 9,000 shares of the company's common stock, according to a new SEC filing. The transaction occurred on August 8, 2024, with the total sale amounting to approximately $1.04 million.

The shares were sold at a weighted average price of $115.35, with individual transactions ranging from $115.30 to $115.46. Following the sale, Andolina's remaining stake in Philip Morris International includes 85,629 shares, which also accounts for 19,830 Restricted Share Units as noted in the SEC filing footnotes.

Investors often monitor insider transactions as they can provide insights into how executives perceive the value of their company's stock. While the reasons behind such sales can vary, they are always a point of interest for market participants looking to understand the internal perspective of a company's leadership.

Philip Morris International, known for its tobacco products, continues to be a significant player in the industry, with its stock performance being closely watched by investors. The details of the sale, including the exact number of shares sold at each price point within the range, have been made available upon request, as stated by the reporting person in the SEC filing.

This transaction comes as part of the routine disclosures that corporate executives are required to make, shedding light on their personal stock holdings and transactions. As of the date of the filing, Massimo Andolina has fulfilled his obligation to report this latest stock sale.

In other recent news, North American companies Qnovia, MIIST Therapeutics, and Greentank are developing vape-like devices to deliver medication for conditions like migraines and asthma. The devices, which are based on nebuliser technology, aim to provide rapid pain relief with fewer side effects than traditional pills. Qnovia and MIIST are launching their products as prescription-only nicotine replacement therapy treatments, while Greentank is targeting the recreational cannabis and nicotine vape market, but also aims to adapt its technology for drug delivery.

In the financial sector, Goldman Sachs has updated its US Conviction List, adding companies like Dollar General (NYSE:DG) and Philip Morris International. This curated list is a guide for investors, indicating stocks that the investment bank believes will outperform the market.

Speaking of Philip Morris International, the company reported robust growth in its recent earnings call and raised its forecasts for 2024. The company's smoke-free products, particularly IQOS, have shown strong momentum in markets such as Japan and Europe, and the user base for IQOS has grown to 30.8 million. Despite some regulatory delays and supply chain constraints, the company is focused on expanding its smoke-free business internationally.

InvestingPro Insights

Philip Morris International Inc. (NYSE:PM) has demonstrated a robust financial performance, which may offer context to the insider transaction involving Massimo Andolina. According to the latest data from InvestingPro, the company boasts an impressive gross profit margin of 63.87% over the last twelve months as of Q2 2024. This figure underscores the company's ability to maintain high levels of profitability within its operations.

Investors keeping an eye on Philip Morris International's stock may also note the company's commitment to shareholder returns, as evidenced by its dividend track record. An InvestingPro Tip highlights that Philip Morris has not only maintained but raised its dividend for 17 consecutive years, reflecting a strong and consistent return to its investors. Additionally, the company's dividend yield as of June 2024 stands at a notable 4.48%, which is particularly attractive for income-focused investors.

The market capitalization of Philip Morris International is valued at $180.31 billion USD, positioning it as a heavyweight in the industry. Furthermore, the company is trading near its 52-week high, with the price being at 97.51% of this peak, which aligns with an InvestingPro Tip that points out the stock's strong return over the last three months, amounting to 17.92%.

It is worth mentioning that there are additional insights available on InvestingPro, with a total of 9 more InvestingPro Tips for Philip Morris, offering deeper analysis for potential investors. These tips and metrics provide a broader understanding of the company's financial health and market performance, which can be especially relevant for those looking to make informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.